Journal article

Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys

OT Ayonrinde, LA Adams, DA Doherty, TA Mori, LJ Beilin, WH Oddy, M Hickey, DM Sloboda, JK Olynyk, R Hart

Journal of Gastroenterology and Hepatology Australia | Published : 2016

Abstract

Background and Aims:: Non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) share risk associations of adiposity and insulin resistance. We examined the impact of a PCOS diagnosis on the metabolic phenotype of adolescent girls with NAFLD and compared this to girls without PCOS or NAFLD and to age-matched boys. Methods:: Community-based adolescents from the Raine Cohort participated in assessments for NAFLD (572 girls and 592 boys) and PCOS (244 girls). One hundred and ninety-nine girls attended both assessments. Results:: Amongst the 199 girls, PCOS was diagnosed in 16.1% and NAFLD in 18.6%. NAFLD was diagnosed in 10.1% of the boys. NAFLD was more prevalent in girls ..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Health and Medical Research Council


Funding Acknowledgements

This work was supported by the National Health and Medical Research Council [project grants (403968, 634445, 353514, 403981, and 634445), a postgraduate scholarship to Oyekoya T. Ayonrinde (404166), National Health and Medical Research Council Practitioner Fellowships to Martha Hickey (1058935) and to John K. Olynyk (1042370) and a research fellowship to Trevor A. Mori, the Gastroenterology Society of Australia (Astra Zeneca Career Development Award to Leon A. Adams), the Fremantle Hospital Medical Research Foundation (medical research grant), and a University of Western Australia Ada Bartholomew grant.